The ARCH uses multi-disciplinary teams and a person-centred approach to examine chronic diseases such as cancer, heart disease, arthritis, diabetes, obesity and dementia.
Reducing epileptic seizures
Epilepsy affects more than 65 million people worldwide and 250,000 people in Australia. It is a debilitating and chronic neurological condition characterised by recurrent brain seizures. More than one-third of people with epilepsy continue to experience seizures during their life.
This project aims to identify strategies to reduce the frequency of epileptic seizures by using transcranial direct-current brain stimulation as an adjunct to usual care. Transcranial direct-current brain stimulation decreases cortical excitability and facilitates synaptic activity in the brain.
By increasing our understanding of how to treat drug-resistant epilepsy, the aim is to reduce the frequency of seizures, improve quality of life for patients and their caregivers, and reduce the need for frequent hospital readmissions.
Find out more about this research initiative.
Non-surgical management of musculoskeletal conditions
Within Australia, the cost of managing chronic conditions, such as osteoarthritis and other musculoskeletal conditions, is unsustainable. These costs are often related to lack of access to evidence-based, effective treatment options.
This project is identifying and testing non-surgical, non-pharmacological treatment options for people with musculoskeletal conditions; identifying barriers and facilitators to accessing these treatment options for people in the northern community; and implementing best practice treatment options into standard practice.
Early supported discharge model for patients with diabetes-related foot disease
Foot disease including ulcers, infection, and lower limb ischaemia accounts for approximately 5% of hospitalisations in Australia.
There are more than 10,000 admissions each year in Australia for diabetes-related foot disease, with an average hospital stay of 26 days. A 2017 Cochrane review found that, for several conditions, early supported discharge improves patient satisfaction, reduces length of stay and does not increase the risk of 30-day readmissions. However, this review found no research on early supported discharge models for patients with diabetes-related foot disease.
The aim of this project is to identify an optimal model of care of early supported discharge for individuals hospitalised with diabetic foot disease and critical limb ischaemia.